<DOC>
	<DOCNO>NCT00246909</DOCNO>
	<brief_summary>Gastroesophageal reflux disease ( GERD ) medical condition affect stomach esophagus . GERD occur low esophageal sphincter close properly stomach content leak back ( reflux ) esophagus . GERD one common medical disorder , estimate 50 % adult report reflux symptom daily . Proton pump inhibitor pantoprazole relieve symptom GERD large proportion patient . Of particular interest GERD assessment symptom severity quality life , response parameter treatment . Therefore , questionnaire ass GERD symptom develop ( ReQuest TradeMark ) . An important point consider use questionnaire evaluate whether observed difference score certain treatment represent clinical effect . The aim study determine minimal clinically important difference ( MCID ) patient diagnose GERD . During study , patient complete patient-orientated , self-assessed reflux questionnaire ( ReQuest TradeMark ) . Endoscopy perform start study . The study duration consist baseline period ( 1 3 week ) treatment period ( 8 week ) . During first treatment week , patient receive either pantoprazole ( tablet ) placebo daily morning ; follow 7 treatment week patient receive pantoprazole . The study provide data safety tolerability pantoprazole .</brief_summary>
	<brief_title>Determination Minimal Clinically Important Difference After Treatment With Pantoprazole Patients With Symptoms Acid Reflux ( Gastroesophageal Reflux Disease ) ( BY1023/M3-340 )</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Main inclusion criterion : In general good health gastroesophageal reflux disease ( GERD ) History GERDrelated symptoms least 6 month prior inclusion study Endoscopically confirm gastroesophageal reflux disease Main exclusion criterion : Acute peptic ulcer and/or ulcer complication Systemic glucocorticoid nonsteroidal antiinflammatory drug ( NSAIDs ) include COX2inhibitors 3 consecutive day within previous 28 day ; except regular intake acetylsalicylic acid dosages 163 mg/day Intake Proton Pump Inhibitors Histamine 2receptor antagonist within previous 14 day Intake psychotropic medication , dyspepsiainducing drug , anticholinergic agent Pregnant nursing female patient ; Nonpregnant , nonlactating female patient childbearing potential use reliable method contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Gastroesophageal Reflux</keyword>
	<keyword>Gastroesophageal Reflux Disease</keyword>
	<keyword>Pantoprazole</keyword>
</DOC>